Comments
Loading...
Imunon (NASDAQ:IMNN) Stock Quotes, Forecast and News Summary
Imunon Stock (NASDAQ: IMNN) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Imunon (IMNN) stock?
You can purchase shares of Imunon (NASDAQ:IMNN) through any online brokerage.
Who are Imunon (IMNN) competitors?
Other companies in Imunon’s space includes: NKGen Biotech (NASDAQ:NKGN), Immuron (NASDAQ:IMRN), Acurx Pharmaceuticals (NASDAQ:ACXP), Cellectar Biosciences (NASDAQ:CLRB) and Can Fite Biofarma (AMEX:CANF).
What is the forecast, or price target, for Imunon (IMNN) stock?
Imunon has a consensus price target of $21.25.
What is the current price for Imunon (IMNN)?
The stock price for Imunon (NASDAQ: IMNN) is $0.8701 last updated February 21, 2025 at 8:44 AM EST.
Does Imunon (IMNN) pay a dividend?
There are no upcoming dividends for Imunon.
When is Imunon (NASDAQ:IMNN) reporting earnings?
Imunon’s Q1 earnings are confirmed for Monday, May 12, 2025.
Is Imunon (IMNN) going to split?
There is no upcoming split for Imunon.
What sector and industry does Imunon (IMNN) operate in?
Imunon is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.